NCT00421629 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Morris SS, Ranson MK, Sinha T, Mills AJ
Measuring improved targeting of health interventions to the poor in the context of a community-randomised trial in rural India. Contemp Clin Trials. 2007 Jul;28(4):382-90. Epub 2006 Oct 14.
Ranson MK, Sinha T, Chatterjee M, Acharya A, Bhavsar A, Morris SS, Mills AJ
Making health insurance work for the poor: learning from the Self-Employed Women's Association's (SEWA) community-based health insurance scheme in India. Soc Sci Med. 2006 Feb;62(3):707-20. Epub 2005 Jul 28.
Ranson MK, Sinha T, Gandhi F, Jayswal R, Mills AJ
Helping members of a community-based health insurance scheme access quality inpatient care through development of a preferred provider system in rural Gujarat. Natl Med J India. 2006 Sep-Oct;19(5):274-82.
Ranson MK, Sinha T, Morris SS, Mills AJ
CRTs--cluster randomized trials or "courting real troubles": challenges of running a CRT in rural Gujarat, India. Can J Public Health. 2006 Jan-Feb;97(1):72-5.
Sinha T, Ranson MK, Chatterjee M, Acharya A, Mills AJ
Barriers to accessing benefits in a community-based insurance scheme: lessons learnt from SEWA Insurance, Gujarat. Health Policy Plan. 2006 Mar;21(2):132-42. Epub 2005 Dec 22.

Experimental Study to Assess Interventions Aimed at Improving the Equity Impact of Community-Based Health Insurance

Clinical trial NCT00421629 - References